Recent Progress and Advances in Stimuli-Responsive Polymers for Cancer Therapy

Area of Science:

• Biomedical Engineering
• Materials Science
• Nanotechnology

Background:

• Conventional chemotherapy faces challenges like non-specificity, systemic toxicity, and low tumor drug concentration.
• Polymeric nanoparticles have emerged as promising carriers for targeted drug delivery.
• Intracellular drug bioavailability and cellular internalization remain key hurdles for nanocarrier systems.

Purpose of the Study:

• To review recent advancements in stimuli-responsive polymers for drug delivery.
• To highlight the potential of stimuli-responsive nanocarriers in overcoming drug delivery barriers.
• To discuss the role of stimuli-responsive systems in improving cancer chemotherapy.

Main Methods:

• Literature review of stimuli-responsive polymers in drug delivery.
• Analysis of nanocarrier systems responding to internal and external stimuli (pH, temperature, redox potential).
• Discussion of strategies for enhanced drug bioavailability and cellular uptake.

Main Results:

• Stimuli-responsive polymers demonstrate significant potential for targeted drug delivery.
• These systems can exploit differences between normal and pathological tissues for precise drug release.
• Advancements in stimuli-responsive nanocarriers offer improved solutions for intracellular delivery barriers.

Conclusions:

• Stimuli-responsive nanocarriers represent a highly promising future direction for drug delivery, particularly in cancer therapy.
• Further research into stimuli-responsive polymers can lead to more effective and less toxic cancer treatments.
• Targeted delivery via stimuli-responsive systems enhances drug efficacy and minimizes side effects.